Cargando…

Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer

Mostrar otras versiones (1)

BACKGROUND: High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamson, A.W., Ding, Y.C., Steele, L., Leong, L.A., Morgan, R., Wakabayashi, M.T., Han, E.S., Dellinger, T.H., Lin, P.S., Hakim, A.A., Wilczynski, S., Warden, C.D., Tao, S., Bedell, V., Cristea, M.C., Neuhausen, S.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980206/ https://www.ncbi.nlm.nih.gov/pubmed/36865331 http://dx.doi.org/10.21203/rs.3.rs-2592107/v1

Ejemplares similares

Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
por: Adamson, A. W., et al.
Publicado: (2023)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Detailed comparison of two popular variant calling packages for exome and targeted exon studies
por: Warden, Charles D., et al.
Publicado: (2014)

RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
por: Clague, Jessica, et al.
Publicado: (2011)

The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations
por: Adamson, Aaron W., et al.
Publicado: (2020)

Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary Cancer Variants in Patients with High-Grade Serous Carcinoma
por: Goebel, Emily A., et al.
Publicado: (2022)

The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high‐grade serous ovarian cancer: a national retrospective audit
por: Frugtniet, B, et al.
Publicado: (2021)

Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer
por: Vendrell, Julie A., et al.
Publicado: (2023)

Deconstructing the evolutionary complexity between rust fungi (Pucciniales) and their plant hosts
por: Aime, M.C., et al.
Publicado: (2018)

Sweet taste perception not altered after acute sleep deprivation in healthy young men
por: Hogenkamp, P.S., et al.
Publicado: (2013)

Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
por: Nath, Aritro, et al.
Publicado: (2021)

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2020)

Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients
por: Ji, Gang, et al.
Publicado: (2021)

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program
por: Care, Melanie, et al.
Publicado: (2020)

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial
por: Aghajanian, Carol, et al.
Publicado: (2022)

Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming
por: Iqbal, Khursheed, et al.
Publicado: (2015)

“DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
por: Wilczyński, Jacek R., et al.
Publicado: (2023)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

Gene Expression Differences in Prostate Cancers between Young and Old Men
por: Ding, Yuanchun, et al.
Publicado: (2016)

The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study
por: Prior, J.A., et al.
Publicado: (2019)

Architectural Histopathological Changes in Ovarian Serous Carcinomas
por: DOCHIȚ, C., et al.
Publicado: (2018)

Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene
por: Dicks, Ed, et al.
Publicado: (2017)

Heat stress and PPE during COVID-19: impact on healthcare workers' performance, safety and well-being in NHS settings
por: Davey, S.L., et al.
Publicado: (2021)

Lower-extremity muscle atrophy and fat infiltration after chronic spinal cord injury
por: Moore, C.D., et al.
Publicado: (2015)

Sex differences in cancer risk among germline p53 mutation carriers
por: Chompret, A, et al.
Publicado: (2004)

Case Report: Double Germline Mutations in BRCA1 and MSH2 in a Patient With Mixed Serous-Endometrioid Endometrial Carcinoma
por: Zheng, Hong, et al.
Publicado: (2020)

Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report
por: Inoue, Kayo, et al.
Publicado: (2020)

Effects of feeding diets with processed Moringa oleifera stem meal on growth and laying performance, and immunological and antioxidant activities in laying ducks
por: Yang, S.L., et al.
Publicado: (2020)

Calorie Anticipation Alters Food Intake After Low-Caloric but Not High-Caloric Preloads
por: Hogenkamp, PS, et al.
Publicado: (2013)

Serous cystadenocarcinoma of the mesentery in a man: case report and review of literature
por: Obuchi, Toru, et al.
Publicado: (2014)

Histopathological Patterns of Microinvasion in Ovarian Serous Borderline Tumors
por: CÎRSTEA, A.E., et al.
Publicado: (2018)

EGFR Immunoexpression in Malignant Serous and Mucinous Ovarian Tumors
por: CÎRSTEA, A.E., et al.
Publicado: (2018)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Building invitro 3D human multicellular models of high-grade serous ovarian cancer
por: Malacrida, Beatrice, et al.
Publicado: (2022)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients
por: IANOSI, N.G., et al.
Publicado: (2018)

Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011)

Tumour morphology predicts PALB2 germline mutation status
por: Teo, Z L, et al.
Publicado: (2013)

STUDIES ON THE CHEMISTRY OF SEROUS EFFUSIONS
por: Epstein, Albert A.
Publicado: (1914)

Germline Copy Number Variation and Ovarian Cancer Survival
por: Fridley, Brooke L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9t2vjddo7hu9n4v4g7ut9eokes